The Dow University of Health Sciences is a public medical university located in the Urban metropolitan area of Karachi, Sindh, Pakistan. It was founded by Sir Hugh Dow, the then Governor of Sindh, in 1945.

During the past decade, Dow University of Health Sciences conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Dow University of Health Sciences" #1 sponsor was "Dow University of Health Sciences" with 28 trials, followed by "Pakistan Institute of Living and Learning" with 6 trials sponsored, "Afshan Amjad Ali" with 1 trials sponsored, "Aga Khan University" with 1 trials sponsored and "Getz Pharma" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dow University of Health Sciences" #1 collaborator was "Dow University of Health Sciences" with 7 trials as a collaborator, "Abbasi Shaheed Hospital" with 5 trials as a collaborator, "University of Manchester" with 4 trials as a collaborator, "Higher Education Commission (Pakistan)" with 3 trials as a collaborator and "Karwan e Hayat" with 2 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Dow University of Health Sciences" are "Bipolar Disorder" (2 trials), "Depression" (2 trials), "Diabetes Mellitus" (2 trials), "Psychosis Not Otherwise Specified" (2 trials) and "Schizoaffective Disorder" (2 trials). Many other conditions were trialed in "Dow University of Health Sciences" in a lesser frequency.

Most popular intervention types in "Dow University of Health Sciences" are "Drug" (15 trials), "Behavioral" (6 trials), "Other" (6 trials), "Procedure" (6 trials) and "Device" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Ondansetron" (2 trials), "Simvastatin" (2 trials), "2% Mepivacaine with 1:100,000 epinephrine" (1 trials) and "3% Mepivacaine Hydrochloride" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dow University of Health Sciences" are 36 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Dow University of Health Sciences". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 32 completed trials in Dow University of Health Sciences, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Dow University of Health Sciences, 2 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 23 trials that are defined as “Not Applicable".

Dow University of Health Sciences has several departments that took part in Clinical trials: "Dow Institute of Physical Medicine and Rehabilitation" - 6 trials